Owners, management and financials
CVR: 27585167
Secondary names: QUANTIBACT A/S
Previous names: LNA BACTERIAL DETECTION A/S, QUANTIBACT A/S
DKK 263,027
Gross profit
Net result: DKK 488,982
Apana Holding ApS (100%)
CVR · view owners
Søren Morgenthaler Echwald
Board: Anette Kofod Echwald (chair) and 2 members
CVR · view management
Active
Founded 1 February 2004
CVR · view overview
1 employee
CVR · 2026
Owner registered: Apana Holding ApS
CVR · 19/02/2020
View the full event history
ANAPA BIOTECH A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named QUANTIBACT A/S and LNA BACTERIAL DETECTION A/S. The management consists of Søren Morgenthaler Echwald. The board consists of Anette Kofod Echwald (chair), Caroline Marie Morgenthaler Echwald and Søren Morgenthaler Echwald. The company is owned by Apana Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 263,027 and a net result of DKK 488,982 compared with DKK 7,646,635 the year before. Equity in the 2025 report amounted to DKK 10,970,173.
Selskabets formål er at drive virksomhed med udvikling og markedsføring af nye metoder til bioteknologisk diagnosticering samt anden hermed forbunden virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | 489 t. | 11 mio. | 11 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | - | 7.6 mio. | 10.5 mio. | 10.5 mio. | - | |
| 202301/01/2023 – 31/12/2023 | - | 1.7 mio. | 3.9 mio. | 2.8 mio. | - | |
| 202201/01/2022 – 31/12/2022 | - | 76 t. | 2.2 mio. | 1.2 mio. | - | |
| 202101/01/2021 – 31/12/2021 | - | 612 t. | 2.1 mio. | 1.1 mio. | - | |
| 202001/01/2020 – 31/12/2020 | - | 472 t. | 1.5 mio. | 472 t. | 1 | |
| 201901/01/2019 – 31/12/2019 | - | -3.8 mio. | 1.7 mio. | 0 | 1 | |
| 201801/01/2018 – 31/12/2018 | - | -693 t. | 4.2 mio. | 3.8 mio. | 1 | |
| 201701/01/2017 – 31/12/2017 | - | -5.2 mio. | 4.9 mio. | 4.5 mio. | 1 | |
| 201601/01/2016 – 31/12/2016 | - | -27 mio. | 10 mio. | 9.7 mio. | 1 | |
| 201501/01/2015 – 31/12/2015 | - | -14.4 mio. | 36.9 mio. | 36.7 mio. | 2 | |
| 201401/01/2014 – 31/12/2014 | - | -1.8 mio. | 52 mio. | 51.1 mio. | 5 | |
| 201301/01/2013 – 31/12/2013 | - | -2.8 mio. | 53.8 mio. | 50.7 mio. | 7 | |
| 201201/01/2012 – 31/12/2012 | 0 | -2.8 mio. | 36.7 mio. | 32.5 mio. | - |
Compared to 1.040 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of ANAPA BIOTECH A/S is 27585167.
ANAPA BIOTECH A/S is owned by Apana Holding ApS.
The management of ANAPA BIOTECH A/S consists of Søren Morgenthaler Echwald.
The board of ANAPA BIOTECH A/S consists of Anette Kofod Echwald, Caroline Marie Morgenthaler Echwald and Søren Morgenthaler Echwald, with Anette Kofod Echwald as chair.
In 2025, ANAPA BIOTECH A/S reported a gross profit of DKK 263,027.
ANAPA BIOTECH A/S had 1 employee in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
ANAPA BIOTECH A/S has published its annual report for 2025. Gross profit came to DKK 263,027, and the net result was DKK 488,982.
Contact info changed: new phone: 25321773, new email: [email protected], new website: www.anapabiotech.com (May 22, 2026).
As of April 21, 2026, Caroline Marie Morgenthaler Echwald has joined the board of directors of ANAPA BIOTECH A/S.
As of March 28, 2026, Anne Margrethe Echwald has left the board of directors of ANAPA BIOTECH A/S.
ANAPA BIOTECH A/S has published its annual report for 2024. Gross profit came to DKK 7,492,906, and the net result was DKK 7,646,635.
ANAPA BIOTECH A/S has published its annual report for 2023. Gross profit came to DKK 1,693,656, and the net result was DKK 1,674,278.
ANAPA BIOTECH A/S has published its annual report for 2022. Gross profit came to DKK 248,788, and the net result was DKK 76,011.
ANAPA BIOTECH A/S has published its annual report for 2021. Gross profit came to DKK 1,011,604, and the net result was DKK 612,196.
ANAPA BIOTECH A/S has published its annual report for 2020. Gross profit came to DKK 525,854, and the net result was DKK 472,071.
ANAPA BIOTECH A/S has published its annual report for 2019. Gross profit came to DKK 104,000, and the net result was DKK -3,813,000.
As of April 24, 2020, EY Godkendt Revisionspartnerselskab has stepped down as auditor of ANAPA BIOTECH A/S.
As of February 19, 2020, Anne Margrethe Echwald has joined the board of directors of ANAPA BIOTECH A/S.
As of February 19, 2020, Søren Morgenthaler Echwald has joined the board of directors of ANAPA BIOTECH A/S.
As of February 19, 2020, Anette Kofod Echwald has joined the board of directors of ANAPA BIOTECH A/S.
As of February 19, 2020, Henrik Torkil Westh has left the board of directors of ANAPA BIOTECH A/S.
As of February 19, 2020, John Riis Mortensen has left the board of directors of ANAPA BIOTECH A/S.
As of February 19, 2020, Karim Tabiti has left the board of directors of ANAPA BIOTECH A/S.
As of February 19, 2020, Apana Holding ApS is registered as an owner of ANAPA BIOTECH A/S with an ownership share of 100%.
ANAPA BIOTECH A/S has published its annual report for 2018. Gross profit came to DKK 236,000, and the net result was DKK -693,000.
ANAPA BIOTECH A/S has published its annual report for 2017. Gross profit came to DKK 360,000, and the net result was DKK -5,166,000.
ANAPA BIOTECH A/S has published its annual report for 2016. Gross profit came to DKK -219,000, and the net result was DKK -27,023,000.
As of September 16, 2016, John Riis Mortensen has joined the board of directors of ANAPA BIOTECH A/S.
As of September 16, 2016, Patrik Olof Dahlén has left the board of directors of ANAPA BIOTECH A/S.
As of September 15, 2016, John Riis Mortensen has left the board of directors of ANAPA BIOTECH A/S.
ANAPA BIOTECH A/S has published its annual report for 2015. Gross profit came to DKK -589,000, and the net result was DKK -14,384,000.
As of November 1, 2015, K P M G C JESPERSEN ÅRHUS I/S has stepped down as auditor of ANAPA BIOTECH A/S.
As of June 8, 2015, Torben Ørskov Pedersen has left the board of directors of ANAPA BIOTECH A/S.
ANAPA BIOTECH A/S has published its annual report for 2014. Gross profit came to DKK -1,317,000, and the net result was DKK -1,825,000.
ANAPA BIOTECH A/S has published its annual report for 2013. Gross profit came to DKK -2,381,000, and the net result was DKK -2,831,000.
As of April 11, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of ANAPA BIOTECH A/S.
On December 13, 2013, the company changed its name from QUANTIBACT A/S to ANAPA BIOTECH A/S.
As of November 15, 2013, Søren Morgenthaler Echwald is registered as adm. dir. of ANAPA BIOTECH A/S.
As of November 15, 2013, Palle Schelde Jensen has stepped down as adm. dir. of ANAPA BIOTECH A/S.
As of May 3, 2013, Karim Tabiti has joined the board of directors of ANAPA BIOTECH A/S.
ANAPA BIOTECH A/S has published its annual report for 2012. Revenue came to DKK 0, and the net result was DKK -2,770,719.
As of November 4, 2011, Patrik Olof Dahlén has joined the board of directors of ANAPA BIOTECH A/S.
As of November 4, 2011, John Riis Mortensen has joined the board of directors of ANAPA BIOTECH A/S.
As of September 22, 2011, Jarne Elleholm has left the board of directors of ANAPA BIOTECH A/S.
As of October 15, 2010, Jarne Elleholm has joined the board of directors of ANAPA BIOTECH A/S.
As of October 15, 2010, Palle Schelde Jensen has left the board of directors of ANAPA BIOTECH A/S.
As of February 1, 2010, Henrik Torkil Westh has joined the board of directors of ANAPA BIOTECH A/S.
As of February 1, 2010, Palle Schelde Jensen has joined the board of directors of ANAPA BIOTECH A/S.
As of February 1, 2010, Palle Schelde Jensen is registered as adm. dir. of ANAPA BIOTECH A/S.
As of February 1, 2010, Henrik Torkil Westh has stepped down as director of ANAPA BIOTECH A/S.
As of September 7, 2009, Torben Ørskov Pedersen has joined the board of directors of ANAPA BIOTECH A/S.
As of September 7, 2009, Henrik Torkil Westh has left the board of directors of ANAPA BIOTECH A/S.
As of May 27, 2009, Henrik Torkil Westh has joined the board of directors of ANAPA BIOTECH A/S.
As of May 12, 2009, Torben Trads Stentoft has left the board of directors of ANAPA BIOTECH A/S.
As of June 25, 2007, Erik Kromann has left the board of directors of ANAPA BIOTECH A/S.
As of April 23, 2007, K P M G C JESPERSEN ÅRHUS I/S has been appointed auditor of ANAPA BIOTECH A/S.
As of April 23, 2007, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of ANAPA BIOTECH A/S.
As of January 5, 2007, Erik Kromann has joined the board of directors of ANAPA BIOTECH A/S.
As of January 5, 2007, Jan Gorm Lisby has left the board of directors of ANAPA BIOTECH A/S.
As of January 5, 2007, Sten Verland has left the board of directors of ANAPA BIOTECH A/S.
On March 23, 2004, the company changed its name from LNA BACTERIAL DETECTION A/S to QUANTIBACT A/S.
As of February 1, 2004, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of ANAPA BIOTECH A/S.
As of February 1, 2004, Jan Gorm Lisby has joined the board of directors of ANAPA BIOTECH A/S.
As of February 1, 2004, Sten Verland has joined the board of directors of ANAPA BIOTECH A/S.
As of February 1, 2004, Torben Trads Stentoft has joined the board of directors of ANAPA BIOTECH A/S.
As of February 1, 2004, Henrik Torkil Westh is registered as director of ANAPA BIOTECH A/S.
ANAPA BIOTECH A/S was founded on February 1, 2004.
Companies in the same industry and area
CVR 29312206
CVR 37053678
CVR 37726028
CVR 29217939
CVR 31762863
